Hi, aquariusgirl.
Yeah, thanks for the slow pitches!!
-)
I continue to struggle with the issue of what should be the form or forms of B12 that a person should try first as part of a methylation-type treatment, and I still don't have a very satifying answer. Different people do seem to respond differently. Please bring me up to date on your experience. I know that the initial simplified protocol with hydroxo B12 did some good things for you at the beginning, and then I recall that you hit a plateau and that switching to methyl B12 was beneficial. Is that correct? What is your situation now with respect to these two forms? Are there things that aren't being resolved by taking either of them as a component of methylation treatment?
It's true that hydroxo B12 does have these downsides, but it did seem to help over two thirds of the women in our clinical study. I realize that for many people it is not feasible to run much in the way of lab tests, either for reasons of finances or inability to get to a physician or phlebotomist, or to find one who will order the tests that require doctor's orders. For those who are able to run lab tests, the picture can be made somewhat clearer, but as you know, there are usually still some unknowns.
With regard to overdriving the methylation cycle, I continue to have concern about that when high dosages of sublingual or injected methyl B12 and high dosages of methylfolate are used together. It makes sense biochemically that this would occur, and the data I've seen from I think three people now does confirm that this does happen. In the cases I've had data from so far, the result of it seemed to be low flow of homocysteine into the transsulfuration pathway and thus low rate of synthesis of glutathione and other sulfur-containing substances. Overdriving the methylation cycle causes the methylation cycle and the folate metabolism to go into a "futile cycle," in which excess methyl groups are passed back and forth between the two by sarcosine and 5-methyl THF. So long as the person has functioning glycine N-methyltransferase, sarcosine dehydrogenase, and MTHFR enzymes, which nearly everyone does, though some have SNPs in MTHFR, this is all that happens. I still have concerns that some may have genomic abnormalities that could cause other effects, though.
I don't know how low the dosages of methylfolate and methyl B12 would need to be to prevent this futile cycle and allow flow into the transsulfuration pathway, but my guess is that a few hundred micrograms per day of the folates and somewhere in the low milligrams per day of methyl B12 would probably be the ranges.
I do think that it is important to get some flow going into the transsulfuration pathway, while also restoring the methylation cycle to more normal flow.
My current suggestion is that if it is not feasible for a person to do lab testing, but if they clearly do have ME/CFS, then they should try the current version of the simplified treatment approach, which uses hydroxo B12 as its B12 form. If they do not experience improvements within 3 months, and they are still not able to do testing, then I suggest that they switch to methyl B12 and see if that helps.
If it is feasible to do lab testing, then I suggest as a minimum that they run the Health Diagnostics and Research Institute (or European Laboratory of Nutrients) methylation pathways panel and the Metametrix plasma 50-amino acids panel, and from these decide whether hydroxo- or methyl-B12 would be the best form to use, based on the levels of SAMe, SAH and glutathione, and decide on whether additional supplements (such as methionine, serine, magnesium, B6 and others) are needed based on the amino acids panel.
In all cases, I continue to recommend that people be monitored by a physician while on this type of treatment, to make sure that if any serious adverse effects arise, they will be recognized early and dealt with promptly and properly.
Best regards,
Rich
HI Rich,
As I have been gathering a variety of information from people to see where the balance of mb12 and methylfolate is and let's throw in potassium while we are at it.
First, there is virtually NO proportionality evidenced between methylb12 and methylfolate as would have to be evident if they linked together to drive the methylation into the hypothetical "overmethylation".
First, here are 4 specific people illustrating a range of quantities.
person 1 - 40,000mgs/day absorbed mb12/adb12, 15000mcg Metafolin, 2000-3000mg potassium
person 2 - 2000mcgs/day absorbed mb12/ADB12, 800mcg Metafolin, 99mg potassium
person 3 - 50-250mcg/day absorbed mb12/adb12, 1600-2400mcg Metafolin, 2100-2800mg potassium (updated when copied)
person 4 - 200mcg/day absorbed mb12, 3200mcg Metafolin, 2400+mg potassium
Range of b12 doses that have turned on healing evidenced by sudden increase in potassium and Metafolin needed
methylb12 dose 15mcg absorbed estimated to 180mg injected daily
adenosylb12 dose - 15mcg absorbed to 10mg absorbed
Methylfolate - person without b12 deficiency, no B12 startup, no methylation startup, no ATP startup - 800mcg
Methylfolate - person with b12 deficiency, b12 startup, methylation startup, ATP startup - 1600-4000mcg
Methylfolate - person with b12 deficiency, methylation startup, ATP startup, paradoxical folate deficiency with folic acid, 6000-8000mcg
Methylfolate - person with b12 deficiency, b12 startup, ATP startup, paradoxical folate deficiency with folic acid and folinic acid-veggie-folate, 12mg - 30mg
Potassium - with b12 deficiency, B12 startup, methylation startup, ATP startup - 1600mg- 3000mg
Potassium - no deficiency, no cfs, no fms, no methylation startup, no ATP startup, no B12 startup, - 99mg
You have suggested that there is some proportionality in healing start-up and I maintained it turned on suddenly. You said that was because of the large doses of mb12. With healing able to "turn on" as low as 15-50mcg absorbed (1/10-1/4 of a 1mg sublingual) mb12 and 200mcg of Metafolin, and then to have the healing so triggered not stop with folate insufficiency symptoms until the doses reached the range above determined NOT by mb12 and/or adb12 dose, but rather by how the person reacts to folic/folinic acid it would appear, and for the potassium to go to that same range in a single sudden jump and sometimes needing relatively minor adjustment in certain predictable circumstances.
Higher doses of mb12 increases greatly the extent, especially CNS and peripheral nerves, and slightly the speed of healing. As many researchers say "B12 allows the body to seek to normal". To relieve the neurological deficiency of adb12 in these people I have recently identified, and hydroxycbl doesn't work and mb12 often doesn't work, and l-carnitine fumarate plus adenosylb12 are both usually needed, mb12 often becoming effective only AFTER the adb12 and l-carnitine, and effective doses of l-carnitine fumarate around 0.5mg before they have absolutely intolerable anxiety, panic etcfrom ATP startup if they have had the adenosylb12 first, otherwise if the have the LCF first then the adb12 has to be micro-titrated from 10mcg or less.. So the person has to titrate slowly along with 200mcg of Metafolin (which causes no particular effects) from < 10mcg of mb12 and < 10mcg of adb12, increasing by like amounts daily until healing turns on. Then the person titrates rapidly on potassium by effect, every couple of hours will do between doses, usually to between 1600 and 2400mg of potassium. Then the person titrates Metafolin by effect every 90 minutes until the folate insufficiency symptoms start decreasing or 3200mcg is reached. Continue the next day if the symptoms continue. Level of folate is determined by type and degree of paradoxical folate deficiency.